Shanghai Biotree Biomedical Technology Co., Ltd.
PrivateLast Round
Series A
Extension
Jan 3, 2023
Total Funding Raised
$16.29M
Company Overview
Shanghai Biotree Biomedical Technology Co., Ltd. is a biotechnology company that provides comprehensive metabolomics, proteomics, and multi-omics testing and analysis services for universities, research institutions, hospitals, and pharmaceutical enterprises.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Biotree Biomedical Technology Co., Ltd. Comparables
Compare Shanghai Biotree Biomedical Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai Bioprofile Technology Co., Ltd. | 93% | |
| Shanghai Applied Protein Technology Co., Ltd. | 92% | |
| Metabo-Profile Biotechnology (Shanghai) Co., Ltd. | 89% |
Shanghai Biotree Biomedical Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 3, 2023 | ||||
| Series A | Jul 15, 2022 | ||||
| Pre Seed | May 1, 2021 | ||||
| Angel | Aug 1, 2018 |
Shanghai Biotree Biomedical Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Qiming Venture Partners | Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 24, 2025
Grew 125% QoQ, from 4 to 9 employees.
- Jan 3, 2023
$1.45M round led by Guangzhou Kingmed Diagnostics Group.
Shanghai Biotree Biomedical Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Shanghai Biotree Biomedical Technology Co., Ltd.'s valuation, stock price, and market status.
Is Shanghai Biotree Biomedical Technology Co., Ltd. a public or private company?
Shanghai Biotree Biomedical Technology Co., Ltd. is a private company.
What is the current stock price of Shanghai Biotree Biomedical Technology Co., Ltd.?
Shanghai Biotree Biomedical Technology Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Shanghai Biotree Biomedical Technology Co., Ltd. worth (valuation)?
Valuation information for Shanghai Biotree Biomedical Technology Co., Ltd. is not publicly available.
Can I buy Shanghai Biotree Biomedical Technology Co., Ltd. stock?
Shanghai Biotree Biomedical Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Shanghai Biotree Biomedical Technology Co., Ltd.'s last funding round?
Shanghai Biotree Biomedical Technology Co., Ltd.'s most recent funding round was Series A Extension on January 3, 2023.
Who are the main investors in Shanghai Biotree Biomedical Technology Co., Ltd.?
Key investors in Shanghai Biotree Biomedical Technology Co., Ltd. include Qiming Venture Partners.
Will Shanghai Biotree Biomedical Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for Shanghai Biotree Biomedical Technology Co., Ltd..
How can I track Shanghai Biotree Biomedical Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Shanghai Biotree Biomedical Technology Co., Ltd.'s secondary market activity and sign up for updates.